DISTRIBUTOR REPORTING Sample Clauses

DISTRIBUTOR REPORTING. (a) Distributor shall comply with the requirements of Nasdaq as to reporting of Reportable Units as set forth in this Agreement and the Nasdaq Requirements. Unless otherwise set forth in the Nasdaq Requirements, Distributor shall use reasonable efforts to provide such reporting within fifteen (15) days of the end of the applicable reporting period set forth by Nasdaq in the Nasdaq Requirements but Nasdaq shall not consider such reporting to be late until forty-five (45) days after the due date.
Sample 1Sample 2Sample 3See All (6)
AutoNDA by SimpleDocs
DISTRIBUTOR REPORTING. DISTRIBUTOR shall complete a series of regular reports as described in Attachment F hereto. The reports are due no later than the 10th day of each month following the end of the respective reporting periods and shall constitute Confidential Information of DISTRIBUTOR. The Parties acknowledge that Applicable Laws or existing contractual relationships with Third-Party Payers may restrict DISTRIBUTOR’s ability to collect, use, include and/or disclose as Data certain patient, payer, and physician-specific data. DISTRIBUTOR shall not provide patient, payer, and physician-specific data and information where so limited by such existing contractual relationships or Applicable Laws. New contracts with Third Party Payers or the enactment of new Applicable Laws may further limit the disclosure of patient- and physician-specific data and information. Neither Party may resell data to IMS, Wolters Kluwer, or any other data aggregation service .
Sample 1Sample 2
DISTRIBUTOR REPORTING. Distributor will report the number of Recipients obtaining Information through the Distributor’s System each month within fifteen (15) days following the calendar end of the applicable month through the reporting service specified by OTC Markets Group, which may be changed from time to time. Distributor shall report the number of Professional Subscribers and Non-Professional Subscribers obtaining the Information. Notwithstanding the foregoing, the Distributor is not required to report the number of Recipients in the case of (i) Information distributed pursuant to a Broker-Dealer License, (ii) Derived Data Usage of the Information, or (iii) Internal Display Usage or External Display Usage of Delayed Data. Non-Display and Derived Data Usage Declaration. Distributor receiving an Uncontrolled Data Feed must declare their Non-Display and Derived Data Usage to OTC Markets Group on an annual basis, by January 31 of each year, or more frequently upon request by OTC Markets Group, by completing the OTC Markets Non-Display and Derived Data Usage Declaration. In the event that Distributor’s use of the Information is or becomes inconsistent with the Non-Display and Derived Data Usage Declaration, Distributor agrees to promptly notify OTC Markets Group and submit a revised declaration for approval by OTC Markets Group.
Sample 1
DISTRIBUTOR REPORTING. DISTRIBUTOR shall complete a series of regular reports as described in Attachment F hereto. The reports are due no later than the 10th of each month following the end of the respective reporting periods and constitute Confidential Information of DISTRIBUTOR. The Parties acknowledge that Applicable Laws or existing contractual relationships with Third-Party Payers may restrict DISTRIBUTOR’s ability to collect, use, include and/or disclose as Data certain patient- and physician-specific data. DISTRIBUTOR warrants that it will not provide patient- and physician-specific data and information where so limited by such existing contractual relationships or Applicable Laws. New contracts with Third Party Payers and the enactment of new Applicable Laws which further limit the disclosure of patient- and physician-specific data and information shall not be deemed to be a change in a law for purposes of this Agreement. Neither Party may resell data to IMS, Wolters Kluwer, or any other data aggregation service without the express written consent of the other Party.
Sample 1
DISTRIBUTOR REPORTING. (a) Distributor shall comply with the requirements of NASDAQ OMX as to reporting of Reportable Units as set forth in this Agreement and the NASDAQ OMX Requirements. Unless otherwise set forth in the NASDAQ OMX Requirements, such reporting shall occur within fifteen (15) days of the end of the applicable reporting period set forth by NASDAQ OMX in the NASDAQ OMX Requirements.
Sample 1

Related to DISTRIBUTOR REPORTING

  • Monthly Reporting Within twenty (20) calendar days following the end of each calendar month, Registry Operator shall deliver to ICANN reports in the format set forth in Specification 3 attached hereto (“Specification 3”).

  • Sales Reports On or before the twentieth (20th) day of each calendar month after the First Month, Tenant shall submit to City a report (the “Sales Report”) showing all Gross Revenues achieved with respect to the prior month by location, segregated by each source or general type of article sold or service rendered. Such report shall be certified as being true and correct by Tenant and shall otherwise be in form and substance satisfactory to Director. As described below, City shall have the right, in addition to all other rights herein, to impose a fine in the event Tenant shall fail to submit such Sales Report timely.

  • Management Reporting (a) Provide periodic reports, in accordance with agreed upon frequency and content parameters, to the Funds. As reasonably requested by the Funds, the Transfer Agent shall furnish ad hoc reports to the Funds.

  • Regulatory Reporting Ultimus agrees to provide reports to the federal and applicable state authorities, including the SEC, and to the Funds’ Auditors. Applicable state authorities are those governmental agencies located in states in which the Fund is registered to sell shares.

  • Quarterly Reporting Within 45 days after the close of the first three (3) quarterly periods of each of its respective fiscal years, to the extent not furnished under the Purchase Agreement, (A) consolidated balance sheets of Provider and its Subsidiaries as at the close of each such period and (B) consolidated statements of income and retained earnings and a statement of cash flows for Provider for the period from the beginning of such fiscal year to the end of such quarter, all certified by its respective chief financial officer or treasurer.

  • Adverse Event Reporting Both Parties acknowledge the obligation to comply with the Protocol and / or applicable regulations governing the collection and reporting of adverse events of which they may become aware during the course of the Clinical Trial. Both Parties agree to fulfil and ensure that their Agents fulfil regulatory requirements with respect to the reporting of adverse events.

  • Account Reporting Information Italian residents who, at any time during the fiscal year, hold foreign financial assets (including cash and shares of Common Stock) which may generate income taxable in Italy are required to report these assets on their annual tax returns (UNICO Form, RW Schedule) for the year during which the assets are held, or on a special form if no tax return is due. These reporting obligations will also apply to Italian residents who are the beneficial owners of foreign financial assets under Italian money laundering provisions.

  • Information Reporting (a) The Fund agrees that, during the Current Special Rate Period and so long as BANA or any Affiliate thereof is the beneficial owner of any Outstanding VRDP Shares, it will deliver, or direct the Tender and Paying Agent to deliver, to BANA and any such Affiliate:

  • Compliance Reporting a. Provide reports to the Securities and Exchange Commission, the National Association of Securities Dealers and the States in which the Fund is registered.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!